Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glisodin and UVB for Treating Vitiligo
NCT03941808Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Dietary Supplement, rProtein (Recombinant Protein), Botanical Extract
- Countries
- 1
01
Overview
Randomised, double-blind trial in Vitiligo comparing Glisodin + Nb-UVB with Placebo + Nb-UVB (2 arms). Primary endpoint: Vitiligo Extent Score at 6 months. Started Jun 2019; status: completed.
02
Drugs
GliSODin
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT03941808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03941808.